Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-027587

Chief Financial Officer gave up 3,444 shares (to pay taxes)

  • Chief Financial Officer acquired 9,956 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tsuchimoto Kim R Chief Financial Officer 2023-09-30 Option exercise +9,956 41,430 D
Tsuchimoto Kim R Chief Financial Officer 2023-09-30 Shares withheld for taxes −3,444 $0.62 $2,135 37,986 D
Derivatives
Tsuchimoto Kim R Chief Financial Officer 2023-09-30 Option exercise · Restricted Stock Units −9,956 105,513 D
Loading xslF345X05/rdgdoc.xml…